Providing investors with the
tools to make informed decisions.
Providing investors with the
tools to make informed decisions.
 Tracking 1136 U.S. listed China Stocks and Counting...
 Tracking 2425 U.S. Stocks and Counting...

 China Nuokang (NASDAQ:NKBP)

Company Description

China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) is a leading biopharmaceutical company in China focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. The Company provides a diversified portfolio of products across more than 2,400 hospitals in China. Nuokang's principal products include Baquting(R), China's leading hemocoagulase product by market share, and Aiduo(R), a cardiovascular stress imaging agent. The Company's product pipeline includes product candidates under development in hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention.

Web site: http://www.nkbp.com

Last updated December 26, 2009